We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Off-Label Neurontin Marketing Costs Pfizer $142 Million
Off-Label Neurontin Marketing Costs Pfizer $142 Million
February 4, 2011
Pfizer has been ordered by a federal court to pay more than $142 million for illegally promoting its anti-seizure medication Neurontin for off-label uses.